REBECCA DUCHON: Open Payments
NPI 1811012602 · ALBUQUERQUE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$200 in 10 payments from 7 companies in 2025. Trend: 2023 $99 · 2024 $15 · 2025 $200
Food & beverage: $200
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 3 | $57 |
| Dexcom, Inc. | 2 | $38 |
| Tandem Diabetes Care, Inc. | 1 | $25 |
| Mallinckrodt Hospital Products Inc. | 1 | $23 |
| Abbott Laboratories | 1 | $20 |
| Acella Pharmaceuticals, LLC | 1 | $19 |
| Ascendis Pharma Endocrinology Inc | 1 | $18 |
Products named: MOUNJARO, Dexcom G6 Transmitter, t:slim X2 Insulin Pump with Control-IQ, ACTHAR, FREESTYLE LIBRE 3, NP Thyroid 60, Yorvipath, ZEPBOUND.
Industry payments across NM — which companies pay providers there.
